Showing 5,501 - 5,520 results of 314,780 for search '"2"', query time: 0.56s Refine Results
  1. 5501
  2. 5502

    Synthesis, crystal structure and Hirshfeld surface analysis of 5-oxo-N-phenyl-3-(thiophen-2-yl)-2,3,4,5-tetrahydro-[1,1′-biphenyl]-4-carboxamide by Khatira N. Aliyeva, Tuncer Hökelek, Victor N. Khrustalev, Rovnag M. Rzayev, Ajaya Bhattarai, Abel M. Maharramov, Namig G. Shikhaliyev

    Published 2025-02-01
    “…The asymmetric unit of the title compound, C23H19NO2S, contains two molecules that differ in the conformation of the two carboxamide moieties. …”
    Get full text
    Article
  3. 5503

    Impact of pathogenic mutations of the GLUT1 glucose transporter on solute carrier dynamics using ComDYN enhanced sampling [version 2; peer review: 2 approved, 1 approved with reservations] by K. Anton Feenstra, Akiko Higuchi, Kei Yura, Sanne Abeln, Halima Mouhib

    Published 2022-06-01
    “…Several pathogenic mutations are reported in the glucose transporter subfamily SLC2, causing Glut1-deficiency syndrome (GLUT1DS1, GLUT1DS2), epilepsy (EIG2) and cryohydrocytosis with neurological defects (Dystonia-9). …”
    Get full text
    Article
  4. 5504
  5. 5505

    Experiences of the International In-Training Examination (I-ITE) by Rwandan pediatric residents – a survey-study describing candidate feedback [version 2; peer review: 1 approved, 2 approved with reservations] by Christian Umuhoza, Natalie McCall, Peter Thomas Cartledge

    Published 2023-01-01
    “…Five themes emerged from the qualitative analysis; 1) undertaking the I-ITE was a positive experience; 2) exam content; 3) formative nature of the assessment; 4) challenges to completing the exam; 5) practicalities to undertaking the exam. …”
    Get full text
    Article
  6. 5506

    Prevalence, aetiology, and service mapping of dementia in rural Uganda. Part of DEPEND Uganda (Dementia Epidemiology, unmet Need and co-Developing Solutions in Uganda). [version 2; peer review: 2 approved] by Joseph Mugisha, Nicholas J Ashton, Claire J Steves, Racheal Alinaitwe, Josephine Prynn, Tunde Peto, Beatrice Kimono, Martin Prince

    Published 2025-01-01
    “…In Part 1, cohort participants are selected based on screening scores to undergo detailed cognitive assessment, using methods developed by the 10/66 Dementia Research Group. Part 2 is a case control study of people with and without dementia using antecedent data, questionnaires, physical assessment, retinal imaging, and Alzheimer’s blood-based biomarkers. …”
    Get full text
    Article
  7. 5507

    A prospective, randomized, single-center, two-arm, open-label study to evaluate the efficacy of biotherapi®, a two-strain bacillus probiotic blend, as an adjunctive therapy in the treatment of rheumatoid arthritis by Arindam Nandy Roy, Yarram Ashok Kumar, Syeda Sana Fatima

    Published 2021-01-01
    “…Methods: In this prospective, randomized, single-center, two-arm, open-label study, patients were randomized (1:1) to receive twice-daily adjunctive Biotherapi® (n = 125) or standard of care alone (n = 125) for 12 weeks. …”
    Get full text
    Article
  8. 5508
  9. 5509
  10. 5510
  11. 5511
  12. 5512
  13. 5513
  14. 5514
  15. 5515
  16. 5516

    Crystal structure of dibromido-(1-methyl-1H-imidazole-κ1N)-(3-(3-methyl-1H-imidazol-3-ium-1-yl)propanoato-κ1O)zinc(II), C11H16Br2N4O2Zn by Liu Pengju, Wang Zongwei, Guo Libing, Tang Junming

    Published 2021-09-01
    “…C11H16Br2N4O2Zn, monoclinic, Cc (no. 9), a = 15.534(7) Å, b = 7.956(4) Å, c = 14.589(7) Å, β = 119.094(8)°, V = 1575.5(13) Å3, Z = 4, Rgt(F) = 0.0296, wRref(F2) = 0.0703, T = 296 K.…”
    Get full text
    Article
  17. 5517
  18. 5518
  19. 5519

    α-细辛醚对秦岭滑蜥断尾后芽基形成时期细胞增殖的影响 by 赵禹 1, 2, 李琳 2, 寇曌婷 2, 高燕燕 2, 邵晓忠 1, 杨纯 1, 2

    Published 2020-01-01
    “…结果显示:PCNA在不同实验分组和不同阶段尾组织中均有表达,在空白组18 d的脊髓中表达最弱,灰度值为188.09±1.98,而实验组20 d的脊髓中表达最强,灰度值为123.10±2.91。实验组的再生尾皮肤组织、肌肉组织和脊髓中PCNA的表达强度均高于空白组和对照组,且对照组与实验组的脊髓中的表达强度具有显著差异(P<0.05)。…”
    Get full text
    Article
  20. 5520